These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34479563)

  • 1. The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle.
    Overbury RS; Stoddard GJ; Pupaibool J; Hansen CB; Lebiedz-Odrobina D
    BMC Health Serv Res; 2021 Sep; 21(1):913. PubMed ID: 34479563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American College of Rheumatology, American Academy of Dermatology, Rheumatologic Dermatology Society, and American Academy of Ophthalmology 2020 Joint Statement on Hydroxychloroquine Use With Respect to Retinal Toxicity.
    Rosenbaum JT; Costenbader KH; Desmarais J; Ginzler EM; Fett N; Goodman SM; O'Dell JR; Schmajuk G; Werth VP; Melles RB; Marmor MF
    Arthritis Rheumatol; 2021 Jun; 73(6):908-911. PubMed ID: 33559327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to Hydroxychloroquine Dosing Guidelines by Rheumatologists: An Electronic Medical Record-Based Study in an Integrated Health Care System.
    Braslow RA; Shiloach M; Macsai MS
    Ophthalmology; 2017 May; 124(5):604-608. PubMed ID: 28153440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatologists' perspective on hydroxychloroquine guidelines.
    Winebrake J; Khalili L; Weiner J; Gartshteyn Y; Park L; Askanase AD
    Lupus Sci Med; 2020 Nov; 7(1):. PubMed ID: 33148665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Weight-Based Dosing Guidelines in Patients Receiving Hydroxychloroquine for Systemic Lupus Erythematosus and Rheumatoid Arthritis: Results of a Quality Improvement Initiative.
    Skorupa T; Shmerling RH
    ACR Open Rheumatol; 2021 Oct; 3(10):733-737. PubMed ID: 34363746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an Electronic Decision Support Tool to Improve Ophthalmic Safety in Hydroxychloroquine Prescribing Practices.
    Chen RI; Kuo BL; Kalur A; Muste JC; Deal C; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2022 Jun; 53(6):310-316. PubMed ID: 35724373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
    AlAhmed O; Way A; Akoghlanian S; Barbar-Smiley F; Lemle S; MacDonald D; Frost E; Wise K; Lee L; Ardoin SP; Sivaraman V
    Lupus; 2021 Feb; 30(2):269-279. PubMed ID: 33307983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial.
    Zanetti CB; Pedrosa T; Kupa LVK; Aikawa NE; Borba EF; Vendramini MBG; Silva CA; Pasoto SG; Bonfa E
    Clin Rheumatol; 2021 Jul; 40(7):2745-2751. PubMed ID: 33486596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.
    Browning DJ; Yokogawa N; Greenberg PB; Perlman E
    Am J Ophthalmol; 2020 Nov; 219():101-106. PubMed ID: 32610049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
    Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
    Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sharp decline in hydroxychloroquine dosing-analysis of 17,797 initiators from 2007 to 2016.
    Melles RB; Jorge AM; Marmor MF; Zhang Y; Choi HK
    Clin Rheumatol; 2018 Jul; 37(7):1853-1859. PubMed ID: 29696437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RetINal Toxicity And HydroxyChloroquine Therapy (INTACT): protocol for a prospective population-based cohort study.
    Daftarian N; Lima A; Marozoff S; Ojo D; Levasseur SD; Maberley DAL; Hoens A; Esdaile J; Dawes M; Aviña-Zubieta JA; Adante B; Bhui RD; Bhui SB; Butler M; Chui L; Erasmus M; Etminan M; Godinho D; Hay E; Hollands H; Hoonjan M; Joe A; Lukaris A; Mammo Z; Navajas E; Pakzad-Vaezi K; Sanmugasunderam S; Shojania K;
    BMJ Open; 2022 Feb; 12(2):e053852. PubMed ID: 35177450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2016 American Academy of Ophthalmology Hydroxychloroquine Dosing Guidelines For Short, Obese Patients.
    Browning DJ; Easterbrook M; Lee C
    Ophthalmol Retina; 2019 Oct; 3(10):809-813. PubMed ID: 31400965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists.
    Shulman S; Wollman J; Brikman S; Padova H; Elkayam O; Paran D
    Lupus; 2017 Mar; 26(3):277-281. PubMed ID: 27440459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
    Pedrosa T; Kupa LVK; Pasoto SG; Aikawa NE; Borba EF; Duarte NJ; Leon EP; Silva CA; Bonfá E
    Lupus; 2021 Apr; 30(4):554-559. PubMed ID: 33402039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatologists' and Rheumatologists' Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: A Cross-Sectional Study.
    Alghamdi AS; AlQefari GB; Alduraibi K; Al-Amer M; Alharbi BA; Alqefari AN; Alqifari HN; Alhameedy MM
    Cureus; 2024 Mar; 16(3):e56179. PubMed ID: 38618426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.
    Jorge AM; Melles RB; Zhang Y; Lu N; Rai SK; Young LH; Costenbader KH; Ramsey-Goldman R; Lim SS; Esdaile JM; Clarke AE; Urowitz MB; Askanase A; Aranow C; Petri M; Choi H
    Arthritis Res Ther; 2018 Jul; 20(1):133. PubMed ID: 29976231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are evidence-based guidelines being followed for the monitoring of ocular toxicity of hydroxychloroquine? A nationwide survey of practice amongst consultant rheumatologists and implications for clinical governance.
    Samanta A; Goh L; Bawendi A
    Rheumatology (Oxford); 2004 Mar; 43(3):346-8. PubMed ID: 14963202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients.
    Green M; Williams L; Boh E; Kuraitis D
    Arch Dermatol Res; 2024 May; 316(5):194. PubMed ID: 38775951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.